Some commonly used TKIs include imatinib, erlotinib, gefitinib, and sunitinib. Each of these drugs targets specific tyrosine kinases associated with different types of cancers. For example, imatinib is used for CML, while erlotinib and gefitinib are often used for non-small cell lung cancer.
